Does SATRALIZUMAB-MWGE Cause Depression? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Depression have been filed in association with SATRALIZUMAB-MWGE. This represents 1.4% of all adverse event reports for SATRALIZUMAB-MWGE.
16
Reports of Depression with SATRALIZUMAB-MWGE
1.4%
of all SATRALIZUMAB-MWGE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Depression From SATRALIZUMAB-MWGE?
Of the 16 reports, 5 (31.3%) required hospitalization.
Is Depression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SATRALIZUMAB-MWGE. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does SATRALIZUMAB-MWGE Cause?
Neuromyelitis optica spectrum disorder (181)
Off label use (87)
Urinary tract infection (87)
Pneumonia (64)
Covid-19 (47)
No adverse event (47)
Fatigue (41)
Headache (36)
Pain (36)
Arthralgia (31)
What Other Drugs Cause Depression?
OXYCODONE (6,871)
ADALIMUMAB (6,340)
APREMILAST (5,129)
ACETAMINOPHEN\OXYCODONE (4,035)
ACETAMINOPHEN\HYDROCODONE (3,699)
METHOTREXATE (3,577)
ETANERCEPT (3,538)
LEVONORGESTREL (3,529)
MORPHINE (3,280)
PREDNISONE (3,211)
Which SATRALIZUMAB-MWGE Alternatives Have Lower Depression Risk?
SATRALIZUMAB-MWGE vs SAXAGLIPTIN
SATRALIZUMAB-MWGE vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SATRALIZUMAB-MWGE vs SCOPOLAMINE
SATRALIZUMAB-MWGE vs SCOPOLAMINE HYDROBROMIDE
SATRALIZUMAB-MWGE vs SEBELIPASE ALFA